1. Home
  2. MAR vs SNY Comparison

MAR vs SNY Comparison

Compare MAR & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marriott International

MAR

Marriott International

HOLD

Current Price

$363.50

Market Cap

97.7B

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$43.93

Market Cap

104.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAR
SNY
Founded
1927
1994
Country
United States
France
Employees
N/A
74846
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.7B
104.5B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
MAR
SNY
Price
$363.50
$43.93
Analyst Decision
Buy
Buy
Analyst Count
16
5
Target Price
$359.31
$58.00
AVG Volume (30 Days)
1.5M
4.2M
Earning Date
05-06-2026
04-23-2026
Dividend Yield
0.76%
3.47%
EPS Growth
14.17
N/A
EPS
2.43
N/A
Revenue
$26,186,000,000.00
N/A
Revenue This Year
$304.38
$3.49
Revenue Next Year
$5.38
$6.10
P/E Ratio
$154.84
$6.14
Revenue Growth
4.33
N/A
52 Week Low
$253.76
$40.89
52 Week High
$410.98
$52.68

Technical Indicators

Market Signals
Indicator
MAR
SNY
Relative Strength Index (RSI) 38.58 54.42
Support Level $345.82 $43.32
Resistance Level $367.50 $45.18
Average True Range (ATR) 8.54 0.76
MACD -2.13 0.22
Stochastic Oscillator 1.15 93.18

Price Performance

Historical Comparison
MAR
SNY

About MAR Marriott International

Marriott operates 1.8 million rooms across roughly 30 brands. At the end of 2025, luxury represented roughly 10% of total rooms, premium was 42%, select service was 46%, and midscale was 2%. Marriott, Courtyard, and Sheraton are the largest brands, while Autograph, Tribute, Moxy, Aloft, and Element are newer lifestyle brands. Managed and franchised represented 99% of total rooms as of Dec. 31, 2025. North America makes up 61% of total rooms. Managed, franchise, and incentive fees represent the vast majority of revenue and profitability for the company.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: